Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,699
Closed -$132K 1579
2024
Q3
$132K Sell
16,699
-6,000
-26% -$52.2K ﹤0.01% 1440
2024
Q2
$202K Sell
22,699
-3,525
-13% -$33.7K ﹤0.01% 1333
2024
Q1
$306K Buy
26,224
+1,768
+7% +$17.7K 0.01% 1177
2023
Q4
$253K Sell
24,456
-10,868
-31% -$103K ﹤0.01% 1204
2023
Q3
$397K Buy
35,324
+6,000
+20% +$75.5K 0.01% 1028
2023
Q2
$337K Sell
29,324
-9,000
-23% -$112K 0.01% 1125
2023
Q1
$533K Sell
38,324
-4,600
-11% -$66.1K 0.01% 916
2022
Q4
$565K Sell
42,924
-16,480
-28% -$220K 0.01% 876
2022
Q3
$834K Buy
+59,404
New +$963K 0.02% 713

Other funds holding EHAB

Oppenheimer & Co's EHAB Position: Q4 2024 in Review

Oppenheimer & Co sold out of Enhabit (EHAB) in Q4 2024, closing a stake of 16,699 shares — an estimated $132K sold.

Oppenheimer & Co first reported a position in EHAB in Q3 2022 and held it in 9 quarters. The position peaked at $834K in Q3 2022. 165 funds tracked by Wall St. Rank hold EHAB as of Q4 2024.

  • Oppenheimer & Co reported no remaining Enhabit position as of Q4 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 16,699 Enhabit shares in Q4 2024, an estimated $132K.
  • Oppenheimer & Co first reported a position in Enhabit in Q3 2022 and held it in 9 quarters.
  • Oppenheimer & Co's Enhabit position peaked at $834K in Q3 2022.
  • 165 funds tracked by Wall St. Rank held Enhabit as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.